300 related articles for article (PubMed ID: 33692106)
1. Microneedle-assisted genome editing: A transdermal strategy of targeting
Wan T; Pan Q; Ping Y
Sci Adv; 2021 Mar; 7(11):. PubMed ID: 33692106
[TBL] [Abstract][Full Text] [Related]
2. Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders.
Tan E; Wan T; Pan Q; Duan J; Zhang S; Wang R; Gao P; Lv J; Wang H; Li D; Ping Y; Cheng Y
Sci Adv; 2024 Apr; 10(16):eadl4336. PubMed ID: 38630829
[TBL] [Abstract][Full Text] [Related]
3. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects.
Deng S; Li X; Liu S; Chen J; Li M; Chew SY; Leong KW; Cheng D
Sci Adv; 2020 Jul; 6(29):eabb4005. PubMed ID: 32832641
[TBL] [Abstract][Full Text] [Related]
4. Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing.
Rui Y; Wilson DR; Choi J; Varanasi M; Sanders K; Karlsson J; Lim M; Green JJ
Sci Adv; 2019 Dec; 5(12):eaay3255. PubMed ID: 31840076
[TBL] [Abstract][Full Text] [Related]
5. Steerable Microneedles Enabling Deep Delivery of Photosensitizers and CRISPR/Cas9 Systems for Effective Combination Cancer Therapy.
Wang T; Chen G; Zhang S; Li D; Wei G; Zhao X; Liu Y; Ding D; Zhang X
Nano Lett; 2023 Sep; 23(17):7990-7999. PubMed ID: 37595030
[TBL] [Abstract][Full Text] [Related]
6. Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment.
Cao J; Zhang N; Wang Z; Su J; Yang J; Han J; Zhao Y
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31096705
[TBL] [Abstract][Full Text] [Related]
7. A CRISPR-Cas9-integrase complex generates precise DNA fragments for genome integration.
Jakhanwal S; Cress BF; Maguin P; Lobba MJ; Marraffini LA; Doudna JA
Nucleic Acids Res; 2021 Apr; 49(6):3546-3556. PubMed ID: 33693715
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting analgesia via targeted in situ repression of Na
Moreno AM; Alemán F; Catroli GF; Hunt M; Hu M; Dailamy A; Pla A; Woller SA; Palmer N; Parekh U; McDonald D; Roberts AJ; Goodwill V; Dryden I; Hevner RF; Delay L; Gonçalves Dos Santos G; Yaksh TL; Mali P
Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692134
[TBL] [Abstract][Full Text] [Related]
9. Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report.
Mirza FN; Wang A; Ramachandran SM; Damsky W; Cohen JM
Br J Dermatol; 2021 Aug; 185(2):432-434. PubMed ID: 33730377
[No Abstract] [Full Text] [Related]
10. Luteolin inhibits NLRP3 inflammasome activation via blocking ASC oligomerization.
Lee MN; Lee Y; Wu D; Pae M
J Nutr Biochem; 2021 Jun; 92():108614. PubMed ID: 33705947
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between IFN-γ and TWEAK through miR-149 amplifies skin inflammation in psoriasis.
Srivastava A; Luo L; Lohcharoenkal W; Meisgen F; Pasquali L; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2021 Jun; 147(6):2225-2235. PubMed ID: 33705829
[TBL] [Abstract][Full Text] [Related]
12. Bioorthogonal catalytic patch.
Chen Z; Li H; Bian Y; Wang Z; Chen G; Zhang X; Miao Y; Wen D; Wang J; Wan G; Zeng Y; Abdou P; Fang J; Li S; Sun CJ; Gu Z
Nat Nanotechnol; 2021 Aug; 16(8):933-941. PubMed ID: 33972760
[TBL] [Abstract][Full Text] [Related]
13. IL-13 modulates ∆Np63 levels causing altered expression of barrier- and inflammation-related molecules in human keratinocytes: A possible explanation for chronicity of atopic dermatitis.
Kubo T; Sato S; Hida T; Minowa T; Hirohashi Y; Tsukahara T; Kanaseki T; Murata K; Uhara H; Torigoe T
Immun Inflamm Dis; 2021 Sep; 9(3):734-745. PubMed ID: 33792188
[TBL] [Abstract][Full Text] [Related]
14. Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma: A Systematic Review and Meta-analysis.
Lam M; Zhu JW; Tadrous M; Drucker AM
JAMA Dermatol; 2021 May; 157(5):549-558. PubMed ID: 33787818
[TBL] [Abstract][Full Text] [Related]
15. Treatment of patients experiencing dupilumab facial redness with itraconazole and fluconazole: A single-institutional, retrospective medical record review.
Gao DX; Song S; Kahn JS; Cohen SR; Fiumara K; Dumont N; Rosmarin D
J Am Acad Dermatol; 2022 Apr; 86(4):938-940. PubMed ID: 33775718
[No Abstract] [Full Text] [Related]
16. Serum sphingosine-1-phosphate is elevated in atopic dermatitis and associated with severity.
Sakai T; Herrmann N; Maintz L; Nümm TJ; Welchowski T; Claus RA; Gräler MH; Bieber T
Allergy; 2021 Aug; 76(8):2592-2595. PubMed ID: 33764548
[No Abstract] [Full Text] [Related]
17. Polyphenols and Cannabidiol Modulate Transcriptional Regulation of Th1/Th2 Inflammatory Genes Related to Canine Atopic Dermatitis.
Massimini M; Dalle Vedove E; Bachetti B; Di Pierro F; Ribecco C; D'Addario C; Pucci M
Front Vet Sci; 2021; 8():606197. PubMed ID: 33763461
[TBL] [Abstract][Full Text] [Related]
18. The CysLT
Voisin T; Perner C; Messou MA; Shiers S; Ualiyeva S; Kanaoka Y; Price TJ; Sokol CL; Bankova LG; Austen KF; Chiu IM
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753496
[TBL] [Abstract][Full Text] [Related]
19. Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis.
Holm JG; Hurault G; Agner T; Clausen ML; Kezic S; Tanaka RJ; Thomsen SF
Dermatology; 2021; 237(4):513-520. PubMed ID: 33730733
[TBL] [Abstract][Full Text] [Related]
20. Targeted genome editing in vivo corrects a Dmd duplication restoring wild-type dystrophin expression.
Maino E; Wojtal D; Evagelou SL; Farheen A; Wong TWY; Lindsay K; Scott O; Rizvi SZ; Hyatt E; Rok M; Visuvanathan S; Chiodo A; Schneeweiss M; Ivakine EA; Cohn RD
EMBO Mol Med; 2021 May; 13(5):e13228. PubMed ID: 33724658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
